img

Global H1N1 Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global H1N1 Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global H1N1 Vaccines market size was US$ 4576.4 million in 2024 and is forecast to a readjusted size of US$ 5708.3 million by 2034 with a CAGR of 3.2% during the forecast period 2024-2034.
The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor for acquiring H1N1 influenza. Moreover, increased research in the field of vaccine technologies and significant government support are driving this market. However, lack of awareness and absence of experienced medical professionals are restraining the growth of H1N1 vaccines market. Furthermore, high capital requirement and stringent regulations are also hindering the growth of the global H1N1 vaccination market.
In terms of sales (consumption) side, this report focuses on the sales of H1N1 Vaccines by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global H1N1 Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global H1N1 Vaccines market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Abbott
Baxter International
Sanofi
GSK
Pfizer
Mitsubishi Tanabe Pharma
Hualan Biological Engineering
Cipla
Merck
Sinovac Biotech
By Type
Intramuscular Vaccines
Intranasal Vaccines
Intradermal Vaccines
By Application
Influenza
Meningococcal
Cervical Cancer
Pneumococcal
Hepatitis
Measles
Mumps
Rubella
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of H1N1 Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of H1N1 Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, H1N1 Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 H1N1 Vaccines Definition
1.2 Market by Type
1.2.1 Global H1N1 Vaccines Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Intramuscular Vaccines
1.2.3 Intranasal Vaccines
1.2.4 Intradermal Vaccines
1.3 Market Segment by Application
1.3.1 Global H1N1 Vaccines Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Influenza
1.3.3 Meningococcal
1.3.4 Cervical Cancer
1.3.5 Pneumococcal
1.3.6 Hepatitis
1.3.7 Measles
1.3.8 Mumps
1.3.9 Rubella
1.3.10 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global H1N1 Vaccines Sales
2.1 Global H1N1 Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global H1N1 Vaccines Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global H1N1 Vaccines Revenue by Region
2.3.1 Global H1N1 Vaccines Revenue by Region (2018-2023)
2.3.2 Global H1N1 Vaccines Revenue by Region (2024-2034)
2.4 Global H1N1 Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global H1N1 Vaccines Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global H1N1 Vaccines Sales Quantity by Region
2.6.1 Global H1N1 Vaccines Sales Quantity by Region (2018-2023)
2.6.2 Global H1N1 Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global H1N1 Vaccines Sales Quantity by Manufacturers
3.1.1 Global H1N1 Vaccines Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global H1N1 Vaccines Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by H1N1 Vaccines Sales in 2024
3.2 Global H1N1 Vaccines Revenue by Manufacturers
3.2.1 Global H1N1 Vaccines Revenue by Manufacturers (2018-2023)
3.2.2 Global H1N1 Vaccines Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by H1N1 Vaccines Revenue in 2024
3.3 Global H1N1 Vaccines Sales Price by Manufacturers
3.4 Global Key Players of H1N1 Vaccines, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of H1N1 Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of H1N1 Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of H1N1 Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global H1N1 Vaccines Sales Quantity by Type
4.1.1 Global H1N1 Vaccines Historical Sales Quantity by Type (2018-2023)
4.1.2 Global H1N1 Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global H1N1 Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global H1N1 Vaccines Revenue by Type
4.2.1 Global H1N1 Vaccines Historical Revenue by Type (2018-2023)
4.2.2 Global H1N1 Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global H1N1 Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global H1N1 Vaccines Price by Type
4.3.1 Global H1N1 Vaccines Price by Type (2018-2023)
4.3.2 Global H1N1 Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global H1N1 Vaccines Sales Quantity by Application
5.1.1 Global H1N1 Vaccines Historical Sales Quantity by Application (2018-2023)
5.1.2 Global H1N1 Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global H1N1 Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global H1N1 Vaccines Revenue by Application
5.2.1 Global H1N1 Vaccines Historical Revenue by Application (2018-2023)
5.2.2 Global H1N1 Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global H1N1 Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global H1N1 Vaccines Price by Application
5.3.1 Global H1N1 Vaccines Price by Application (2018-2023)
5.3.2 Global H1N1 Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America H1N1 Vaccines Sales by Company
6.1.1 North America H1N1 Vaccines Revenue by Company (2018-2023)
6.1.2 North America H1N1 Vaccines Sales Quantity by Company (2018-2023)
6.2 North America H1N1 Vaccines Market Size by Type
6.2.1 North America H1N1 Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America H1N1 Vaccines Revenue by Type (2018-2034)
6.3 North America H1N1 Vaccines Market Size by Application
6.3.1 North America H1N1 Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America H1N1 Vaccines Revenue by Application (2018-2034)
6.4 North America H1N1 Vaccines Market Size by Country
6.4.1 North America H1N1 Vaccines Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America H1N1 Vaccines Revenue by Country (2018-2034)
6.4.3 North America H1N1 Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe H1N1 Vaccines Sales by Company
7.1.1 Europe H1N1 Vaccines Sales Quantity by Company (2018-2023)
7.1.2 Europe H1N1 Vaccines Revenue by Company (2018-2023)
7.2 Europe H1N1 Vaccines Market Size by Type
7.2.1 Europe H1N1 Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe H1N1 Vaccines Revenue by Type (2018-2034)
7.3 Europe H1N1 Vaccines Market Size by Application
7.3.1 Europe H1N1 Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe H1N1 Vaccines Revenue by Application (2018-2034)
7.4 Europe H1N1 Vaccines Market Size by Country
7.4.1 Europe H1N1 Vaccines Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe H1N1 Vaccines Revenue by Country (2018-2034)
7.4.3 Europe H1N1 Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China H1N1 Vaccines Sales by Company
8.1.1 China H1N1 Vaccines Sales Quantity by Company (2018-2023)
8.1.2 China H1N1 Vaccines Revenue by Company (2018-2023)
8.2 China H1N1 Vaccines Market Size by Type
8.2.1 China H1N1 Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China H1N1 Vaccines Revenue by Type (2018-2034)
8.3 China H1N1 Vaccines Market Size by Application
8.3.1 China H1N1 Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China H1N1 Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC H1N1 Vaccines Sales by Company
9.1.1 APAC H1N1 Vaccines Sales Quantity by Company (2018-2023)
9.1.2 APAC H1N1 Vaccines Revenue by Company (2018-2023)
9.2 APAC H1N1 Vaccines Market Size by Type
9.2.1 APAC H1N1 Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC H1N1 Vaccines Revenue by Type (2018-2034)
9.3 APAC H1N1 Vaccines Market Size by Application
9.3.1 APAC H1N1 Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC H1N1 Vaccines Revenue by Application (2018-2034)
9.4 APAC H1N1 Vaccines Market Size by Region
9.4.1 APAC H1N1 Vaccines Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC H1N1 Vaccines Revenue by Region (2018-2034)
9.4.3 APAC H1N1 Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America H1N1 Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America H1N1 Vaccines Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America H1N1 Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America H1N1 Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America H1N1 Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America H1N1 Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America H1N1 Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America H1N1 Vaccines Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America H1N1 Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Overview
11.1.3 Abbott H1N1 Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Abbott H1N1 Vaccines Products and Services
11.1.5 Abbott H1N1 Vaccines SWOT Analysis
11.1.6 Abbott Recent Developments
11.2 Baxter International
11.2.1 Baxter International Company Information
11.2.2 Baxter International Overview
11.2.3 Baxter International H1N1 Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Baxter International H1N1 Vaccines Products and Services
11.2.5 Baxter International H1N1 Vaccines SWOT Analysis
11.2.6 Baxter International Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi H1N1 Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Sanofi H1N1 Vaccines Products and Services
11.3.5 Sanofi H1N1 Vaccines SWOT Analysis
11.3.6 Sanofi Recent Developments
11.4 GSK
11.4.1 GSK Company Information
11.4.2 GSK Overview
11.4.3 GSK H1N1 Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 GSK H1N1 Vaccines Products and Services
11.4.5 GSK H1N1 Vaccines SWOT Analysis
11.4.6 GSK Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer H1N1 Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Pfizer H1N1 Vaccines Products and Services
11.5.5 Pfizer H1N1 Vaccines SWOT Analysis
11.5.6 Pfizer Recent Developments
11.6 Mitsubishi Tanabe Pharma
11.6.1 Mitsubishi Tanabe Pharma Company Information
11.6.2 Mitsubishi Tanabe Pharma Overview
11.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Products and Services
11.6.5 Mitsubishi Tanabe Pharma H1N1 Vaccines SWOT Analysis
11.6.6 Mitsubishi Tanabe Pharma Recent Developments
11.7 Hualan Biological Engineering
11.7.1 Hualan Biological Engineering Company Information
11.7.2 Hualan Biological Engineering Overview
11.7.3 Hualan Biological Engineering H1N1 Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Hualan Biological Engineering H1N1 Vaccines Products and Services
11.7.5 Hualan Biological Engineering H1N1 Vaccines SWOT Analysis
11.7.6 Hualan Biological Engineering Recent Developments
11.8 Cipla
11.8.1 Cipla Company Information
11.8.2 Cipla Overview
11.8.3 Cipla H1N1 Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Cipla H1N1 Vaccines Products and Services
11.8.5 Cipla H1N1 Vaccines SWOT Analysis
11.8.6 Cipla Recent Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Overview
11.9.3 Merck H1N1 Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Merck H1N1 Vaccines Products and Services
11.9.5 Merck H1N1 Vaccines SWOT Analysis
11.9.6 Merck Recent Developments
11.10 Sinovac Biotech
11.10.1 Sinovac Biotech Company Information
11.10.2 Sinovac Biotech Overview
11.10.3 Sinovac Biotech H1N1 Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Sinovac Biotech H1N1 Vaccines Products and Services
11.10.5 Sinovac Biotech H1N1 Vaccines SWOT Analysis
11.10.6 Sinovac Biotech Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 H1N1 Vaccines Value Chain Analysis
12.2 H1N1 Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 H1N1 Vaccines Production Mode & Process
12.4 H1N1 Vaccines Sales and Marketing
12.4.1 H1N1 Vaccines Sales Channels
12.4.2 H1N1 Vaccines Distributors
12.5 H1N1 Vaccines Customers
13 Market Dynamics
13.1 H1N1 Vaccines Industry Trends
13.2 H1N1 Vaccines Market Drivers
13.3 H1N1 Vaccines Market Challenges
13.4 H1N1 Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global H1N1 Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Intramuscular Vaccines
Table 3. Major Manufacturers of Intranasal Vaccines
Table 4. Major Manufacturers of Intradermal Vaccines
Table 5. Global H1N1 Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global H1N1 Vaccines Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global H1N1 Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global H1N1 Vaccines Revenue Market Share by Region (2018-2023)
Table 9. Global H1N1 Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global H1N1 Vaccines Revenue Market Share by Region (2024-2034)
Table 11. Global H1N1 Vaccines Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 12. Global H1N1 Vaccines Sales by Region (2018-2023) & (K Units)
Table 13. Global H1N1 Vaccines Sales Market Share by Region (2018-2023)
Table 14. Global H1N1 Vaccines Sales by Region (2024-2034) & (K Units)
Table 15. Global H1N1 Vaccines Sales Market Share by Region (2024-2034)
Table 16. Global H1N1 Vaccines Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 17. Global H1N1 Vaccines Sales Quantity Share by Manufacturers (2018-2023)
Table 18. Global H1N1 Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global H1N1 Vaccines Revenue Share by Manufacturers (2018-2023)
Table 20. Global H1N1 Vaccines Price by Manufacturers 2018-2023 (USD/Unit)
Table 21. Global Key Players of H1N1 Vaccines, Industry Ranking, 2021 VS 2024
Table 22. Global H1N1 Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global H1N1 Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H1N1 Vaccines as of 2024)
Table 24. Global Key Manufacturers of H1N1 Vaccines, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of H1N1 Vaccines, Product Offered and Application
Table 26. Global Key Manufacturers of H1N1 Vaccines, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global H1N1 Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 29. Global H1N1 Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global H1N1 Vaccines Sales Quantity Share by Type (2018-2023)
Table 31. Global H1N1 Vaccines Sales Quantity Share by Type (2024-2034)
Table 32. Global H1N1 Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global H1N1 Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global H1N1 Vaccines Revenue Share by Type (2018-2023)
Table 35. Global H1N1 Vaccines Revenue Share by Type (2024-2034)
Table 36. H1N1 Vaccines Price by Type (2018-2023) & (USD/Unit)
Table 37. Global H1N1 Vaccines Price Forecast by Type (2024-2034) & (USD/Unit)
Table 38. Global H1N1 Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 39. Global H1N1 Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global H1N1 Vaccines Sales Quantity Share by Application (2018-2023)
Table 41. Global H1N1 Vaccines Sales Quantity Share by Application (2024-2034)
Table 42. Global H1N1 Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global H1N1 Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global H1N1 Vaccines Revenue Share by Application (2018-2023)
Table 45. Global H1N1 Vaccines Revenue Share by Application (2024-2034)
Table 46. H1N1 Vaccines Price by Application (2018-2023) & (USD/Unit)
Table 47. Global H1N1 Vaccines Price Forecast by Application (2024-2034) & (USD/Unit)
Table 48. North America H1N1 Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 49. North America H1N1 Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 50. North America H1N1 Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America H1N1 Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America H1N1 Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 53. North America H1N1 Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America H1N1 Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 55. North America H1N1 Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America H1N1 Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 57. North America H1N1 Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America H1N1 Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 59. North America H1N1 Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 60. North America H1N1 Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America H1N1 Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 62. North America H1N1 Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe H1N1 Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 64. Europe H1N1 Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 65. Europe H1N1 Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 66. Europe H1N1 Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe H1N1 Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe H1N1 Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe H1N1 Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Europe H1N1 Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe H1N1 Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe H1N1 Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe H1N1 Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 74. Europe H1N1 Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe H1N1 Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe H1N1 Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 77. Europe H1N1 Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China H1N1 Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 79. China H1N1 Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 80. China H1N1 Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 81. China H1N1 Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China H1N1 Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 83. China H1N1 Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 84. China H1N1 Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 85. China H1N1 Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China H1N1 Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 87. China H1N1 Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC H1N1 Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 89. APAC H1N1 Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 90. APAC H1N1 Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 91. APAC H1N1 Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC H1N1 Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 93. APAC H1N1 Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC H1N1 Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 95. APAC H1N1 Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC H1N1 Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 97. APAC H1N1 Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC H1N1 Vaccines Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 99. APAC H1N1 Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 100. APAC H1N1 Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC H1N1 Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 102. APAC H1N1 Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity by Company (2018-2023) & (K Units)
Table 104. Middle East, Africa and Latin America H1N1 Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America H1N1 Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America H1N1 Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America H1N1 Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America H1N1 Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America H1N1 Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America H1N1 Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America H1N1 Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 117. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Abbott Company Information
Table 119. Abbott Description and Overview
Table 120. Abbott H1N1 Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 121. Abbott H1N1 Vaccines Product and Services
Table 122. Abbott H1N1 Vaccines SWOT Analysis
Table 123. Abbott Recent Developments
Table 124. Baxter International Company Information
Table 125. Baxter International Description and Overview
Table 126. Baxter International H1N1 Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 127. Baxter International H1N1 Vaccines Product and Services
Table 128. Baxter International H1N1 Vaccines SWOT Analysis
Table 129. Baxter International Recent Developments
Table 130. Sanofi Company Information
Table 131. Sanofi Description and Overview
Table 132. Sanofi H1N1 Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 133. Sanofi H1N1 Vaccines Product and Services
Table 134. Sanofi H1N1 Vaccines SWOT Analysis
Table 135. Sanofi Recent Developments
Table 136. GSK Company Information
Table 137. GSK Description and Overview
Table 138. GSK H1N1 Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 139. GSK H1N1 Vaccines Product and Services
Table 140. GSK H1N1 Vaccines SWOT Analysis
Table 141. GSK Recent Developments
Table 142. Pfizer Company Information
Table 143. Pfizer Description and Overview
Table 144. Pfizer H1N1 Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 145. Pfizer H1N1 Vaccines Product and Services
Table 146. Pfizer H1N1 Vaccines SWOT Analysis
Table 147. Pfizer Recent Developments
Table 148. Mitsubishi Tanabe Pharma Company Information
Table 149. Mitsubishi Tanabe Pharma Description and Overview
Table 150. Mitsubishi Tanabe Pharma H1N1 Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 151. Mitsubishi Tanabe Pharma H1N1 Vaccines Product and Services
Table 152. Mitsubishi Tanabe Pharma H1N1 Vaccines SWOT Analysis
Table 153. Mitsubishi Tanabe Pharma Recent Developments
Table 154. Hualan Biological Engineering Company Information
Table 155. Hualan Biological Engineering Description and Overview
Table 156. Hualan Biological Engineering H1N1 Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 157. Hualan Biological Engineering H1N1 Vaccines Product and Services
Table 158. Hualan Biological Engineering H1N1 Vaccines SWOT Analysis
Table 159. Hualan Biological Engineering Recent Developments
Table 160. Cipla Company Information
Table 161. Cipla Description and Overview
Table 162. Cipla H1N1 Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 163. Cipla H1N1 Vaccines Product and Services
Table 164. Cipla H1N1 Vaccines SWOT Analysis
Table 165. Cipla Recent Developments
Table 166. Merck Company Information
Table 167. Merck Description and Overview
Table 168. Merck H1N1 Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 169. Merck H1N1 Vaccines Product and Services
Table 170. Merck H1N1 Vaccines SWOT Analysis
Table 171. Merck Recent Developments
Table 172. Sinovac Biotech Company Information
Table 173. Sinovac Biotech Description and Overview
Table 174. Sinovac Biotech H1N1 Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 175. Sinovac Biotech H1N1 Vaccines Product and Services
Table 176. Sinovac Biotech H1N1 Vaccines SWOT Analysis
Table 177. Sinovac Biotech Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. H1N1 Vaccines Distributors List
Table 181. H1N1 Vaccines Customers List
Table 182. H1N1 Vaccines Market Trends
Table 183. H1N1 Vaccines Market Drivers
Table 184. H1N1 Vaccines Market Challenges
Table 185. H1N1 Vaccines Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. H1N1 Vaccines Product Picture
Figure 2. Global H1N1 Vaccines Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global H1N1 Vaccines Market Share by Type in 2024 & 2034
Figure 4. Intramuscular Vaccines Product Picture
Figure 5. Intranasal Vaccines Product Picture
Figure 6. Intradermal Vaccines Product Picture
Figure 7. Global H1N1 Vaccines Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global H1N1 Vaccines Market Share by Application in 2024 & 2034
Figure 9. Influenza
Figure 10. Meningococcal
Figure 11. Cervical Cancer
Figure 12. Pneumococcal
Figure 13. Hepatitis
Figure 14. Measles
Figure 15. Mumps
Figure 16. Rubella
Figure 17. Others
Figure 18. H1N1 Vaccines Report Years Considered
Figure 19. Global H1N1 Vaccines Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 20. Global H1N1 Vaccines Revenue 2018-2034 (US$ Million)
Figure 21. Global H1N1 Vaccines Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 22. Global H1N1 Vaccines Sales Quantity 2018-2034 (K Units)
Figure 23. Global H1N1 Vaccines Sales Quantity Market Share by Region (2018-2023)
Figure 24. Global H1N1 Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 25. North America H1N1 Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. North America H1N1 Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Europe H1N1 Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Europe H1N1 Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 29. China H1N1 Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 30. China H1N1 Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 31. APAC H1N1 Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 32. APAC H1N1 Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 33. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 34. Middle East, Africa and Latin America H1N1 Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 35. The Top 10 and Top 5 Players Market Share by H1N1 Vaccines Sales Quantity in 2024
Figure 36. The Top 10 and Top 5 Players Market Share by H1N1 Vaccines Revenue in 2024
Figure 37. H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 38. Global H1N1 Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 39. Global H1N1 Vaccines Revenue Market Share by Type (2018-2034)
Figure 40. Global H1N1 Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 41. Global H1N1 Vaccines Revenue Market Share by Application (2018-2034)
Figure 42. North America H1N1 Vaccines Revenue Market Share by Company in 2024
Figure 43. North America H1N1 Vaccines Sales Quantity Market Share by Company in 2024
Figure 44. North America H1N1 Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 45. North America H1N1 Vaccines Revenue Market Share by Type (2018-2034)
Figure 46. North America H1N1 Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 47. North America H1N1 Vaccines Revenue Market Share by Application (2018-2034)
Figure 48. North America H1N1 Vaccines Revenue Share by Country (2018-2034)
Figure 49. North America H1N1 Vaccines Sales Quantity Share by Country (2018-2034)
Figure 50. U.S. H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 51. Canada H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 52. Europe H1N1 Vaccines Sales Quantity Market Share by Company in 2024
Figure 53. Europe H1N1 Vaccines Revenue Market Share by Company in 2024
Figure 54. Europe H1N1 Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 55. Europe H1N1 Vaccines Revenue Market Share by Type (2018-2034)
Figure 56. Europe H1N1 Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 57. Europe H1N1 Vaccines Revenue Market Share by Application (2018-2034)
Figure 58. Europe H1N1 Vaccines Revenue Share by Country (2018-2034)
Figure 59. Europe H1N1 Vaccines Sales Quantity Share by Country (2018-2034)
Figure 60. Germany H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 61. France H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 62. U.K. H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 63. Italy H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 64. Russia H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 65. China H1N1 Vaccines Sales Quantity Market Share by Company in 2024
Figure 66. China H1N1 Vaccines Revenue Market Share by Company in 2024
Figure 67. China H1N1 Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 68. China H1N1 Vaccines Revenue Market Share by Type (2018-2034)
Figure 69. China H1N1 Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 70. China H1N1 Vaccines Revenue Market Share by Application (2018-2034)
Figure 71. APAC H1N1 Vaccines Sales Quantity Market Share by Company in 2024
Figure 72. APAC H1N1 Vaccines Revenue Market Share by Company in 2024
Figure 73. APAC H1N1 Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 74. APAC H1N1 Vaccines Revenue Market Share by Type (2018-2034)
Figure 75. APAC H1N1 Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 76. APAC H1N1 Vaccines Revenue Market Share by Application (2018-2034)
Figure 77. APAC H1N1 Vaccines Revenue Share by Region (2018-2034)
Figure 78. APAC H1N1 Vaccines Sales Quantity Share by Region (2018-2034)
Figure 79. Japan H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 80. South Korea H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 81. China Taiwan H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 82. Southeast Asia H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 83. India H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 84. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity Market Share by Company in 2024
Figure 85. Middle East, Africa and Latin America H1N1 Vaccines Revenue Market Share by Company in 2024
Figure 86. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 87. Middle East, Africa and Latin America H1N1 Vaccines Revenue Market Share by Type (2018-2034)
Figure 88. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 89. Middle East, Africa and Latin America H1N1 Vaccines Revenue Market Share by Application (2018-2034)
Figure 90. Middle East, Africa and Latin America H1N1 Vaccines Sales Quantity Share by Country (2018-2034)
Figure 91. Middle East, Africa and Latin America H1N1 Vaccines Revenue Share by Country (2018-2034)
Figure 92. Brazil H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 93. Mexico H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 94. Turkey H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 95. Israel H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 96. GCC Countries H1N1 Vaccines Revenue (2018-2034) & (US$ Million)
Figure 97. H1N1 Vaccines Value Chain
Figure 98. H1N1 Vaccines Production Process
Figure 99. Channels of Distribution (Direct Vs Distribution)
Figure 100. Distributors Profiles
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries